Lonza Divests Capsules & Health Ingredients Business for $3 Billion
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Mergers & Acquisitions (M&A)
Kearney Report Signals Chemicals M&A Rebound
Kearney's 2026 Chemicals Executive M&A Report forecasts strengthened global deal activity after 2025 gains, with executives anticipating more small-to-mid-size transactions.
Asahi Kasei Acquires Aicuris for €780 Million
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
Alkermes Completes $2.1 Billion Acquisition of Avadel Pharmaceuticals
Alkermes has finalized its acquisition of Avadel Pharmaceuticals, bolstering its presence in the sleep medicine market.
Sanofi Completes Acquisition of Dynavax for $2.2 Billion
Sanofi has completed its acquisition of Dynavax, adding its adult vaccines and pipeline candidates to strengthen Sanofi’s presence in adult immunization.
Umicore PMC Integrates HTS and Ligand Services from Solvias
Umicore Precious Metals Chemistry (Umicore PMC) has acquired high-throughput screening (HTS) and specialty ligand technologies from Solvias, with services transitioning during 2026.
Henkel to Acquire Coatings Company Stahl for €2.1 Billion
Henkel has agreed to acquire Dutch-based specialty coatings company Stahl for €2.1 billion to strengthen and expand its Adhesive Technologies business into adjacent high-performance coatings markets.
GSK to Acquire RAPT Therapeutics for $2.2 Billion
GSK announced a definitive agreement to acquire RAPT Therapeutics for $2.2 billion, gaining rights to ozureprubart, a next-generation treatment that could protect food allergy patients.
Agno Pharma Acquires US cGMP API Manufacturing Site
Agno Pharma acquired Actylis's Eugene, Oregon CDMO facility, formerly Cascade Chemistry, for small-molecule API development and manufacturing, thereby expanding its US footprint.
HSH Chemie Group Acquires Two Sweetener Companies
The acquisitions strengthens HSH Chemie’s sweetener and sugar alternatives
portfolio, adding established fructose expertise, long-standing customer
relationships, and international market access.
Arkema and Praana Announce Proposed Transaction in Plastic Additives
Arkema and Praana Group announced that they have entered into a proposed transaction under which Praana would acquire selected plastic additives businesses from Arkema.
Dystar Aquired by Zhejiang Longsheng Group
Dystar has become a wholly owned subsidiary of Zhejiang Longsheng Group following the $688.9 million buyout of KIRI Industries’ 37.5% stake, marking the end of a long shareholder dispute.
Four Ways to Win amid Uncertainty
Strong Supply Chains, Efficiency, Digitalization, and Talent Development are Crucial for Chemical Distributors
AkzoNobel Completes $1.4 Billion Sale of AkzoNobel India to JSW Group
Akzo Nobel has completed the sale of Akzo Nobel India, including its liquid paints and coatings business, to the JSW Group for an enterprise value of about €1.4 billion.
CABB Group to Sell Jayhawk Fine Chemicals to Anupam Rasayan
CABB Group has signed a definitive agreement to sell its US-based subsidiary Jayhawk Fine Chemicals to Anupam Rasayan, marking Anupam’s entry into US manufacturing and supporting CABB’s strategic focus on pharma.
Asahi Kasei and Teijin Establish Distribution Joint Venture
The two Japanese companies Asahi Kasei and Teijin are merging their trading divisions.
Harbour Group's Americo Acquires Fusion
Harbour Group's Americo has acquired Fusion Chemical, a specialty metalworking fluids manufacturer based in Huntington, Indiana, expanding its product offerings and capacity for growth.
Halozyme Acquires Drug Delivery Company Elektrofi
Halozyme has acquired Elektrofi to expand its drug delivery portfolio, with royalty revenues expected to start by 2030 as partnered products advance to clinical development.
Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion
Johnson & Johnson is acquiring clinical-stage biotech Halda Therapeutics for $3.05 billion to enhance its oncology pipeline.
Brenntag Acquires Chem Tech Services
The acquisition builds on Brenntag's significant market position in oil and gas and serves the growing energy market in North America.
AkzoNobel and Axalta Announce $25 Billion Merger
AkzoNobel and Axalta have agreed to merge in an all-stock deal, creating a global coatings leader with $17 billion in revenue, a $25 billion enterprise value, and significant synergies expected within three years.
IMCD Acquires Dong Yang FT to Expand in South Korean Beauty Sector
IMCD ito acquire Dong Yang FT to enhance its position in the beauty and personal care market in South Korea.
Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
BASF Sells Majority Stake in Coatings Business
BASF sells a majority stake in its coatings business to the investor Carlyle.
Harke Pharma Acquires Groundbreaking Memory Complex
Harke Pharma has completed the acquisition of a highly acclaimed nutraceutical Memory Complex originally developed by Green Bioactives, UK.
Carlyle Leads Potential BASF Coatings Deal
Private equity firm Carlyle is leading discussions to acquire the coatings division of German chemical giant BASF, a source familiar with the matter told Reuters.
Safic-Alcan Acquires Anders, Expands in Latin America
Safic-Alcan has expanded its reach in Latin America with the acquisition of Anders, strengthening its position and portfolio within the region's specialty chemicals market.
BASF Sells Food and Health Performance Ingredients Unit
The transaction includes the production site in Illertissen, Germany, three application laboratories outside Germany, and ~300 employees who have transferred to Louis Dreyfus Company (LDC) as part of the acquisition.
Pfizer Agrees to Take Over Metsera for $4.9 Billion
Pfizer to acquire Metsera, a New York, NY-based clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
Prange Pharma Acquires Site in Italy from MSD
Prange Pharma is taking over a production site from MSD Animal Health in Aprilia, Italy. A new center for contract manufacturing in the field of animal health products is to be established there.
Roche to Acquire 89Bio in $3.5 Billion Deal
Acquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination development.
Symeres Acquires DGr Pharma
CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.
Jungbunzlauer Acquires Illinois Plant to Establish US Manufacturing
Jungbunzlauer to acquire from International Flavors & Fragrances (IFF) a multipurpose site in Thomson, IL, establishing a US manufacturing footprint.
IMCD to Acquire Tillmanns
IMCD, a partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Tillmanns.
Safic-Alcan Acquire Ingredients Plus, Strengthening APAC Position
Safic-Alcan, a distributor of specialty chemicals, announces the acquisition of Ingredients Plus, a specialty chemicals distributor with a strong historical presence in the personal care sector in Malaysia and Singapore.
Eastman Chemical Company
Aditya Birla Group
CABB Group GmbH
Cabot Corporation
Henkel AG & Co. KGaA
Accenture
Deutsche Post DHL
Ineos
Gilead Sciences, Inc.
Agilent Technologies Inc.
EuroAPI
Caldic Deutschland Chemie B. V.
Süd Chemie
Rhodia Europe
Pricewaterhouse Coopers
EvaluatePharma
A.T. Kearney GmbH
SK Pharmteco
Immedica Pharma AB
Kemira Oyj
Wacker Chemie
Bakelite Synthetics
DistriConsult GmbH
DKSH
Safic-Alcan
DuPont Company
Bachem
Novo Nordisk A/S
Ashland
Ter Hell & Co. GmbH
BASF SE
Nova Chemicals
Emerson Automation Solutions
CHEManager c/o Wiley-VCH Verlag
Kearney
Nouryon
Bilfinger SE
Bio-Rad Laboratories
Zeta GmbH
HAS Healthcare Advanced Synthesis SA
The Dow Chemical Company
GlaxoSmithKline (GSK) plc
Lonza AG
Simon-Kucher & Partners Strategy & Marketing Consultants GmbH
Archroma
Röhm GmbH
F. Hoffmann-La Roche Ltd
Harke Group GmbH
Brenntag SE
Biogen Inc.